The global antibody production market size is calculated at USD 24.80 billion in 2024, grew to USD 28.04 billion in 2025, and is predicted to hit around USD 84.72 billion by 2034, poised to grow at a CAGR of 13.07% between 2024 and 2034. The North America antibody production market size accounted for USD 9.92 billion in 2024 and is anticipated to grow at the fastest CAGR of 13.21% during the forecast year.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Antibody Production Market
5.1. COVID-19 Landscape: Antibody Production Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Antibody Production Market, By Product
8.1. Antibody Production Market Revenue and Volume Forecast, by Product, 2024-2034
8.1.1. Instruments
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Consumables
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
8.1.3. Software
8.1.3.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 9. Global Antibody Production Market, By Process
9.1. Antibody Production Market Revenue and Volume Forecast, by Process, 2024-2034
9.1.1. Upstream Processing
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Downstream Processing
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 10. Global Antibody Production Market, By Type
10.1. Antibody Production Market Revenue and Volume Forecast, by Type, 2024-2034
10.1.1. Monoclonal Antibody
10.1.1.1. Market Revenue and Volume Forecast (2021-2034)
10.1.2. Polyclonal Antibody
10.1.2.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 11. Global Antibody Production Market, By End-use
11.1. Antibody Production Market Revenue and Volume Forecast, by End-use, 2024-2034
11.1.1. Pharmaceutical and Biotechnology Companies
11.1.1.1. Market Revenue and Volume Forecast (2021-2034)
11.1.2. Research Laboratories
11.1.2.1. Market Revenue and Volume Forecast (2021-2034)
11.1.3. CROs and CDMOs
11.1.3.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 12. Global Antibody Production Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.1.2. Market Revenue and Volume Forecast, by Process (2021-2034)
12.1.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.1.4. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.1.5.2. Market Revenue and Volume Forecast, by Process (2021-2034)
12.1.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.1.5.4. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.1.6.2. Market Revenue and Volume Forecast, by Process (2021-2034)
12.1.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.1.6.4. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.2.2. Market Revenue and Volume Forecast, by Process (2021-2034)
12.2.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.2.4. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.2.5.2. Market Revenue and Volume Forecast, by Process (2021-2034)
12.2.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.2.5.4. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.2.6.2. Market Revenue and Volume Forecast, by Process (2021-2034)
12.2.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.2.6.4. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.2.7.2. Market Revenue and Volume Forecast, by Process (2021-2034)
12.2.7.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.2.7.4. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.2.8.2. Market Revenue and Volume Forecast, by Process (2021-2034)
12.2.8.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.2.8.4. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.3.2. Market Revenue and Volume Forecast, by Process (2021-2034)
12.3.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.3.4. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.3.5.2. Market Revenue and Volume Forecast, by Process (2021-2034)
12.3.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.3.5.4. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.3.6.2. Market Revenue and Volume Forecast, by Process (2021-2034)
12.3.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.3.6.4. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.3.7.2. Market Revenue and Volume Forecast, by Process (2021-2034)
12.3.7.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.3.7.4. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.3.8.2. Market Revenue and Volume Forecast, by Process (2021-2034)
12.3.8.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.3.8.4. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.4.2. Market Revenue and Volume Forecast, by Process (2021-2034)
12.4.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.4.4. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.4.5.2. Market Revenue and Volume Forecast, by Process (2021-2034)
12.4.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.4.5.4. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.4.6.2. Market Revenue and Volume Forecast, by Process (2021-2034)
12.4.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.4.6.4. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.4.7.2. Market Revenue and Volume Forecast, by Process (2021-2034)
12.4.7.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.4.7.4. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.4.8.2. Market Revenue and Volume Forecast, by Process (2021-2034)
12.4.8.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.4.8.4. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.5.2. Market Revenue and Volume Forecast, by Process (2021-2034)
12.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.5.4. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.5.5.2. Market Revenue and Volume Forecast, by Process (2021-2034)
12.5.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.5.5.4. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.5.6.2. Market Revenue and Volume Forecast, by Process (2021-2034)
12.5.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.5.6.4. Market Revenue and Volume Forecast, by End-use (2021-2034)
Chapter 13. Company Profiles
13.1. QIAGEN
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Thermo Fisher Scientific, Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. PerkinElmer, Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. BGI
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Illumina, Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Agilent Technologies
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Pacific Biosciences of California, Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. ProPhase Labs, Inc. (Nebula Genomics)
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Psomagen
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Azenta US, Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample